Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder
![Loading Loading](https://www.cmaj.ca/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Abstract
Background: In Canada, low awareness of evidence-based interventions for the clinical management of alcohol use disorder exists among health care providers and people who could benefit from care. To address this gap, the Canadian Research Initiative in Substance Misuse convened a national committee to develop a guideline for the clinical management of high-risk drinking and alcohol use disorder.
Methods: Development of this guideline followed the ADAPTE process, building upon the 2019 British Columbia provincial guideline for alcohol use disorder. A national guideline committee (consisting of 36 members with diverse expertise, including academics, clinicians, people with lived and living experiences of alcohol use, and people who self-identified as Indigenous or Métis) selected priority topics, reviewed evidence and reached consensus on the recommendations. We used the Appraisal of Guidelines for Research and Evaluation Instrument (AGREE II) and the Guidelines International Network’s Principles for Disclosure of Interests and Management of Conflicts to ensure the guideline met international standards for transparency, high quality and methodological rigour. We rated the final recommendations using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) tool; the recommendations underwent external review by 13 national and international experts and stakeholders.
Recommendations: The guideline includes 15 recommendations that cover screening, diagnosis, withdrawal management and ongoing treatment, including psychosocial treatment interventions, pharmacotherapies and community-based programs. The guideline committee identified a need to emphasize both underused interventions that may be beneficial and common prescribing and other practice patterns that are not evidence based and that may potentially worsen alcohol use outcomes.
Interpretation: The guideline is intended to be a resource for physicians, policymakers and other clinical and nonclinical personnel, as well as individuals, families and communities affected by alcohol use. The recommendations seek to provide a framework for addressing a large burden of unmet treatment and care needs for alcohol use disorder within Canada in an evidence-based manner.
See related article at www.cmaj.ca/lookup/doi/10.1503/cmaj.231015
This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/
In this issue
Article tools
Jump to section
Related Articles
Cited By...
- Preoccupations en ce qui concerne la recommandation contre la prescription dinhibiteurs selectifs de la recapture de la serotonine dans la Ligne directrice canadienne pour la prise en charge clinique de la consommation dalcool a risque eleve et du trouble dutilisation de lalcool
- Gestion des risques associes aux antidepresseurs chez les personnes ayant un trouble dutilisation de lalcool
- Analyse de la position de la Ligne directrice canadienne sur les inhibiteurs selectifs du recaptage de la serotonine dans un contexte de trouble lie a lusage dalcool et de troubles de lhumeur et anxieux concomitants
- Harms and costs of proposed changes in how alcohol is sold in Ontario
- Addressing the risks of antidepressants among people with alcohol use disorders
- Navigating the nuances of the Canadian guidelines stance on selective serotonin reuptake inhibitors in concurrent alcohol use disorder and mood or anxiety disorders
- Concerns regarding the recommendation against prescribing selective serotonin reuptake inhibitors in the Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder
- Trouble grave lie a lutilisation dalcool apres linstauration dun traitement par inhibiteur selectif du recaptage de la serotonine
- Severe alcohol use disorder after initiation of selective serotonin reuptake inhibitor therapy
Podcast